ChiCTR2400092811
正在进行
/
/
/
2024-11-25
/
/
Chronic diseases
Personalised Lifestyle Medicine in Mid-life Project
Personalised Lifestyle Medicine in Mid-life Project
The specific objectives are: 1. Assessing the undiagnosed hypertension and diabetes mellites (DM) prevalence among those aged 35-59 of the Hong Kong population. 2. Using a cohort approach, to provide intervention to at-risk subjects and change their lifestyle behaviour and biometric measures in short term (6 months). 3. Establish a cohort with longer follow up time (10 years) to facilitate the development of a Hong Kong adapted prediction model of cardiovascular disease (CVD). 4. Assessing the cost-effectiveness of the intervention.
单臂
其它
Not necessary
/
The Hong Kong Jockey Club Charities Trust
/
20000
/
2022-02-14
2025-06-30
/
1) Aged between 35 – 59. 2) Without doctor-diagnosed chronic diseases and require medication (including diabetes, hypertension, cardiovascular diseases, chronic obstructive pulmonary diseases, depression, autoimmune diseases, and cancer). 3) Not in the waiting list for follow-up healthcare services in the public or private sector because of the listed chronic diseases above.；
请登录查看1) Those who cannot provide consent. 2) Pregnant women. 3) Do not understand Cantonese.；
请登录查看JC School of Public Health and Primary Care, CUHK
/
JC School of Public Health and Primary Care, CUHK的其他临床试验
- Personalised Lifestyle Medicine in Mid-life Project
- Health Coaching with Physical Monitoring using Health Wearable (HCHW) to prevent noncommunicable diseases (NCDs) in the middle-aged: a 4-arms randomized controlled trial
- Health Coaching with Physical Monitoring using Health Wearable (HCHW) to prevent noncommunicable diseases (NCDs) in the middle-aged: a 4-arms adaptive randomized controlled trial
JC School of Public Health and Primary Care, The Chinese University of Hong Kong的其他临床试验
- Personalised Lifestyle Medicine in Mid-life Project
- Effects of Behavioural Activation With Mindfulness and Physical Exercise (BAMPE) on Mental Health: A Randomized Controlled Trial
- Effects of stand-alone mindfulness practices for people with long COVID-19 symptoms: A randomized controlled trial
- 慢性腰背痛症者對靜觀治療的支付意願和偏好
- Online integrated mindfulness-meaning programme for depression and anxiety during COVID-19: A pilot randomized controlled trial
- 專科門診病人經驗調查 2018/19
- 對香港自閉症譜系兒童及其家庭進行正念訓練改善其健康狀况
- 正念认知疗法治疗自杀幸存者预试验
- 兩個临床證據質量評估工具的可靠性比較：隨機對照試驗
- 以社區為基礎的隊列研究 - 使用全自動視網膜圖像分析（ARIA）來評估中風風險與生活方式的關系
- Electroacupuncture and Wrist Splinting for Carpal Tunnel Syndrome: A Randomized Trial in Primary Care Setting
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构：国家药品监督管理局 2026-09-10
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构：国家市场监督管理总局 2026-09-18
-
颁布机构：国家市场监督管理总局 2026-09-17
-
颁布机构：国家市场监督管理总局 2026-08-10